Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3501410012 | Clorazepate dipotassium 3.75 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3677767017 | Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3677768010 | Dipotassium clorazepate 3.75 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4569321000052113 | dikaliumklorazepat 3,75 milligram, oral tablett | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug) | Is a | bensodiazepinsedativ | false | Inferred relationship | Some | ||
| Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing clorazepate (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug) | Is a | dikaliumklorazepat | false | Inferred relationship | Some | ||
| Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Benzodiazepine sedative (substance) | false | Inferred relationship | Some | ||
| Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Dipotassium clorazepate | false | Inferred relationship | Some | ||
| Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
| Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Dipotassium clorazepate | false | Inferred relationship | Some | 1 | |
| Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Dipotassium clorazepate | true | Inferred relationship | Some | 1 | |
| Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug) | har täljarvärde som visar styrka | 3,75 | false | Inferred relationship | Some | 1 | |
| Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug) | har nämnarvärde som visar styrka | ett | false | Inferred relationship | Some | 1 | |
| Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Dipotassium clorazepate | true | Inferred relationship | Some | 1 | |
| Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Clorazepate-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug) | räkning av bas i aktiv ingrediens | ett | false | Inferred relationship | Some | ||
| Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Clorazepate only product in oral dose form | true | Inferred relationship | Some | ||
| Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing benzodiazepine (product) | false | Inferred relationship | Some | ||
| Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
FHIR